Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder [Phase 1]
Phase 1 trial assessing safety and effectiveness of cortical stimulation for major depressive disorder. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: Antidepressant Incomplete Response Depression
AstraZeneca-sponsored clinical trial addressing antidepressant-incomplete response in major depressive disorder has completed.
-
FDA approval · 2009-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride, resulting in changes to the …
-
FDA approval · 2009-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Actavis Pharma, confirming approval of a generic version.
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder [Phase 2]
This is an open-label Phase 2 clinical trial evaluating duloxetine for treating major depressive disorder in children and adolescents; the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-12-04FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA (olanzapine) filed by Eli Lilly and Company, expanding the regulatory scope of the produ…
-
FDA label_change · 2009-12-02FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, likely involving changes to the drug's la…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Phenytoin as an Augmentation for SSRI Failures [Phase 4]
Phase 4 clinical trial evaluating phenytoin as augmentation for SSRI failures in depression has completed.
-
FDA approval · 2009-11-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis, a generic sustained-release formulation.
-
CLINICAL_TRIALS research · 2009-11-16Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression [Phase 2]
A Phase 2 trial evaluating transcranial direct current stimulation for treatment-resistant major depressive disorder has completed.
-
FDA approval · 2009-11-09FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth/Pfizer, adding the extended-r…
-
FDA approval · 2009-11-09FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride extended-release (XL) from Actavis Pharma, enabling the generic prod…
-
FDA approval · 2009-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for bupropion hydrochloride (Epic Pharma LLC) under ANDA 075932. This approval updates the approved …
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating the safety and efficacy of escitalopram in pediatric major depressive disorder completed, with results posted in 20…
-
CLINICAL_TRIALS research · 2009-10-30Clinical Trial Update: Culturally Sensitive Depression Care Management for Latino Primary Care Patients [Phase 2]
Phase 2 clinical trial evaluating culturally sensitive depression care management for Latino primary care patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure [NA]
A completed trial evaluating EEG-guided pharmacotherapy for patients with major depressive disorder who failed previous treatments.
-
FDA approval · 2009-10-26FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for NORPRAMIN (desipramine hydrochloride) from Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2009-10-22Clinical Trial Update: Brain Abnormalities in Late-Onset Major Depression
A completed clinical trial investigating brain abnormalities in patients with late-onset major depressive disorder.
-
CLINICAL_TRIALS research · 2009-10-16Clinical Trial Update: Work Hour Reductions, Medical Errors, and Intern Well-Being at Providence St. Vincent Medical Center Intensive Care Unit [NA]
A completed clinical trial at Providence St. Vincent Medical Center examining how work-hour reductions affect medical errors and intern well…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome [Phase 2]
A Phase 2 clinical trial evaluated combining antidepressant medication with psychotherapy for insomnia to improve depressive symptoms in ind…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic Treatment [NA]
This clinical trial update reports that the study NCT00993876 evaluating cognitive flexibility and cognitive performance in major depression…
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression [Phase 2]
Phase 2 clinical trial evaluating the H-Coil Transcranial Magnetic Stimulation device as augmentation for drug-resistant depression has comp…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Effect of Aerobic Training on Asthmatic Patients [NA]
This completed clinical trial evaluated the effect of aerobic training in patients with asthma. Outcomes included airway inflammation and co…
-
CLINICAL_TRIALS research · 2009-10-02Clinical Trial Update: The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF) [NA]
This clinical trial update discusses the potential impact of SSRI treatment on mood symptoms and fertility treatment outcomes in women under…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression [Phase 4]
Phase 4 study evaluating duloxetine in hospitalized patients with severe major depressive disorder has completed and results were posted.